{
    "Trade/Device Name(s)": [
        "Visby Medical Respiratory Health Test"
    ],
    "Submitter Information": "Visby Medical, Inc.",
    "510(k) Number": "K242526",
    "Predicate Device Reference 510(k) Number(s)": [
        "K220963"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF"
    ],
    "Summary Letter Date": "August 23, 2024",
    "Summary Letter Received Date": "August 26, 2024",
    "Submission Date": "February 16, 2025",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "SARS-CoV-2 RNA",
        "Influenza A RNA",
        "Influenza B RNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Anterior nasal swab"
    ],
    "Specimen Container(s)": [
        "Visby Medical Respiratory Health Buffer"
    ],
    "Instrument(s)/Platform(s)": [
        "Visby Medical Respiratory Health Test (self-contained device)"
    ],
    "Method(s)/Technology(ies)": [
        "Reverse Transcription Polymerase Chain Reaction (RT-PCR)",
        "Colorimetric detection"
    ],
    "Methodologies": [
        "RT-PCR",
        "Nucleic acid amplification and detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Reagent",
        "Platform"
    ],
    "Document Summary": "FDA 510(k) summary for Visby Medical Respiratory Health Test, a single-use, self-contained RT-PCR assay for qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B from nasal swab specimens.",
    "Indications for Use Summary": "Single-use automated RT-PCR test for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B RNA in nasopharyngeal and anterior nasal swab specimens from symptomatic individuals, aiding differential diagnosis in conjunction with clinical assessment.",
    "fda_folder": "Microbiology"
}